UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?

Blood cancer journal (New York), 2020-01, Vol.10 (1), p.10, Article 10

Ferrara, Felicetto

2020

Link zum Volltext

Verfügbarkeit prüfen

Acute myeloid leukaemia in adults

The Lancet (British edition), 2013-02, Vol.381 (9865), p.484-495

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of Covid-19 on the treatment of acute myeloid leukemia

Leukemia, 2020-08, Vol.34 (8), p.2254-2256

2020

Link zum Volltext

Verfügbarkeit prüfen

Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults

The New England journal of medicine, 2020-10, Vol.383 (17), p.1613-1623

2020

Link zum Volltext

Verfügbarkeit prüfen

Is There Still a Role for Autologous Stem Cell Transplantation for the Treatment of Acute Myeloid Leukemia?

Cancers, 2019-12, Vol.12 (1), p.59

2019

Link zum Volltext

Verfügbarkeit prüfen

Current Therapeutic Results and Treatment Options for Older Patients with Relapsed Acute Myeloid Leukemia

Cancers, 2019-02, Vol.11 (2), p.224

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy

BMC health services research, 2023-01, Vol.23 (1), p.36-36, Article 36

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia

Haematologica (Roma), 2019-02, Vol.104 (2), p.312-318

2019

Link zum Volltext

Verfügbarkeit prüfen

National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?

BMC cancer, 2020-10, Vol.20 (1), p.956-12, Article 956

2020

Link zum Volltext

Verfügbarkeit prüfen

Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy

Frontiers in oncology, 2024, Vol.14, p.1367393-1367393

2024

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic Workup of Acute Myeloid Leukemia: What Is Really Necessary? An Italian Survey

Frontiers in oncology, 2022-02, Vol.12, p.828072-828072

2022

Link zum Volltext

Verfügbarkeit prüfen

MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?

Frontiers in oncology, 2022-07, Vol.12, p.890871-890871

2022

Link zum Volltext

Verfügbarkeit prüfen

Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells

Nature Medicine, 2005-01, Vol.11 (1), p.77-84

2005

Link zum Volltext

Verfügbarkeit prüfen

Physician's Attitude Towards Treatment of Older Patients and the Choice of Therapy

Mediterranean journal of hematology and infectious diseases, 2013-01, Vol.5 (1), p.e2013025-e2013025

Ferrara, Felicetto

2013

Link zum Volltext

Verfügbarkeit prüfen

Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10

Journal of clinical oncology, 2009-11, Vol.27 (32), p.5397-5403

2009

Link zum Volltext

Verfügbarkeit prüfen

Guadecitabine: a new therapeutic option for acute myeloid leukaemia?

The lancet oncology, 2017-10, Vol.18 (10), p.1287-1288

Ferrara, Felicetto

2017

Link zum Volltext

Verfügbarkeit prüfen

2021 BSH guidelines for the management of adult myelodysplastic syndromes: a practical approach to a challenging disease

British journal of haematology, 2021-07, Vol.194 (2), p.235-237

2021

Link zum Volltext

Verfügbarkeit prüfen

HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or b

PloS one, 2013-12, Vol.8 (12), p.e83018

2013

Link zum Volltext

Verfügbarkeit prüfen

Real-world treatments and clinical outcomes in unfit AML patients receiving first-line treatment or best supportive care in Italy (CURRENT study)

Leukemia research reports, 2024, Vol.21, p.100453, Article 100453

2024

Link zum Volltext

Verfügbarkeit prüfen

Extramedullary Involvement at Relapse in Acute Promyelocytic Leukemia Patients Treated or Not With All-Trans Retinoic Acid: A Report by the Gruppo Italiano Malattie Ematologiche dell’Adulto

Journal of clinical oncology, 2001-10, Vol.19 (20), p.4023-4028

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 304

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(292)
Mit Volltextzugriff
(268)

Publikationsform

Artikel
(304)

Sprache

Englisch
(304)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(181)
Life Sciences & Biomedicine
(180)
Humans
(170)
Hematology
(134)
Female
(120)
Male
(120)
Middle Aged
(112)
Aged
(100)
Adult
(88)
Oncology
(74)
Biological And Medical Sciences
(67)
Medical Sciences
(67)
Treatment Outcome
(57)
Adolescent
(52)
Hematologic And Hematopoietic Diseases
(52)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(51)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(50)
Acute Myeloid Leukemia
(47)
Remission Induction
(37)
Aged, 80 And Over
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?

Acute myeloid leukaemia in adults

Impact of Covid-19 on the treatment of acute myeloid leukemia

Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults

Is There Still a Role for Autologous Stem Cell Transplantation for the Treatment of Acute Myeloid Leukemia?

Current Therapeutic Results and Treatment Options for Older Patients with Relapsed Acute Myeloid Leukemia

Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy

Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia

National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?

Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy

Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts

Diagnostic Workup of Acute Myeloid Leukemia: What Is Really Necessary? An Italian Survey

MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?

BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients

AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance

Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells

Physician's Attitude Towards Treatment of Older Patients and the Choice of Therapy

Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10

Guadecitabine: a new therapeutic option for acute myeloid leukaemia?

Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience

Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers

2021 BSH guidelines for the management of adult myelodysplastic syndromes: a practical approach to a challenging disease

HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or b

Real-world treatments and clinical outcomes in unfit AML patients receiving first-line treatment or best supportive care in Italy (CURRENT study)

Extramedullary Involvement at Relapse in Acute Promyelocytic Leukemia Patients Treated or Not With All-Trans Retinoic Acid: A Report by the Gruppo Italiano Malattie Ematologiche dell’Adulto

Suchergebnisse filtern